Vascular Graft Market (Product Type: Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, Bypass Graft, and Others; Source: Synthetic, Biological, and Biosynthetic) - Global Industry Analysis, Size, Share, Growth, Trends, and Fo

Vascular Graft Market (Product Type: Endovascular Stent Graft, Peripheral Vascular Graft, Hemodialysis Access Graft, Bypass Graft, and Others; Source: Synthetic, Biological, and Biosynthetic) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

LaMaitre Vascular, Inc.
B. Braun Melsungen AG
C. R. Bard, Inc.
Cook Medical
Medtronic plc
ArteGrafts, Inc.
Vascutek Ltd.
Vascular Grafts Solution Ltd.
Heart Medical Europe BV
W. L. Gore & Associates, Inc.

Countries

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 2.6

Forecast Year (last) Value - 4.7

CAGR % - 0.053

Currency - US$ Bn


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vascular Graft Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Vascular Graft Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Top 3 players operating in the market space
5.4. COVID-19 Impact Analysis
6. Global Vascular Graft Market Analysis and Forecast, By Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Endovascular Stent Graft
6.3.2. Peripheral Vascular Graft
6.3.3. Hemodialysis Access Graft
6.3.4. Bypass Graft
6.3.5. Others
6.4. Market Attractiveness Analysis, By Product Type
7. Global Vascular Graft Market Analysis and Forecast, By Source
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Source, 2017–2031
7.3.1. Synthetic
7.3.1.1. Polytetrafluethylene (PTFE)
7.3.1.2. Polyurethane (PU)
7.3.1.3. Dacron
7.3.1.4. Others
7.3.2. Biological
7.3.2.1. Bovine Vein
7.3.2.2. Saphenous Vein
7.3.2.3. Others
7.3.3. Biosynthetic
7.3.3.1. Ovine Collagen with Polyester
7.3.3.2. Others
7.4. Market Attractiveness Analysis, By Source
8. Global Vascular Graft Market Analysis and Forecast, By Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Coronary Artery Disease
8.3.2. Aneurysm
8.3.3. Vascular Occlusion
8.3.4. Renal Failure
8.3.5. Others
8.4. Market Attractiveness Analysis, By Application
9. Global Vascular Graft Market Analysis and Forecast, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Cardiac Catheterization Laboratories
9.3.4. Specialty Clinics
9.3.5. Others
9.4. Market Attractiveness Analysis, By End-user
10. Global Vascular Graft Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Country/Region
11. North America Vascular Graft Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Endovascular Stent Graft
11.2.2. Peripheral Vascular Graft
11.2.3. Hemodialysis Access Graft
11.2.4. Bypass Graft
11.2.5. Others
11.3. Market Value Forecast, by Source, 2017–2031
11.3.1. Synthetic
11.3.1.1. Polytetrafluethylene (PTFE)
11.3.1.2. Polyurethane (PU)
11.3.1.3. Dacron
11.3.1.4. Others
11.3.2. Biological
11.3.2.1. Bovine Vein
11.3.2.2. Saphenous Vein
11.3.2.3. Others
11.3.3. Biosynthetic
11.3.3.1. Ovine Collagen with Polyester
11.3.3.2. Others
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Coronary Artery Disease
11.4.2. Aneurysm
11.4.3. Vascular Occlusion
11.4.4. Renal Failure
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Cardiac Catheterization Laboratories
11.5.4. Specialty Clinics
11.5.5. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Source
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Vascular Graft Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Endovascular Stent Graft
12.2.2. Peripheral Vascular Graft
12.2.3. Hemodialysis Access Graft
12.2.4. Bypass Graft
12.2.5. Others
12.3. Market Value Forecast, by Source, 2017–2031
12.3.1. Synthetic
12.3.1.1. Polytetrafluethylene (PTFE)
12.3.1.2. Polyurethane (PU)
12.3.1.3. Dacron
12.3.1.4. Others
12.3.2. Biological
12.3.2.1. Bovine Vein
12.3.2.2. Saphenous Vein
12.3.2.3. Others
12.3.3. Biosynthetic
12.3.3.1. Ovine Collagen with Polyester
12.3.3.2. Others
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Coronary Artery Disease
12.4.2. Aneurysm
12.4.3. Vascular Occlusion
12.4.4. Renal Failure
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Cardiac Catheterization Laboratories
12.5.4. Specialty Clinics
12.5.5. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Source
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Vascular Graft Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Endovascular Stent Graft
13.2.2. Peripheral Vascular Graft
13.2.3. Hemodialysis Access Graft
13.2.4. Bypass Graft
13.2.5. Others
13.3. Market Value Forecast, by Source, 2017–2031
13.3.1. Synthetic
13.3.1.1. Polytetrafluethylene (PTFE)
13.3.1.2. Polyurethane (PU)
13.3.1.3. Dacron
13.3.1.4. Others
13.3.2. Biological
13.3.2.1. Bovine Vein
13.3.2.2. Saphenous Vein
13.3.2.3. Others
13.3.3. Biosynthetic
13.3.3.1. Ovine Collagen with Polyester
13.3.3.2. Others
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Coronary Artery Disease
13.4.2. Aneurysm
13.4.3. Vascular Occlusion
13.4.4. Renal Failure
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Cardiac Catheterization Laboratories
13.5.4. Specialty Clinics
13.5.5. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Source
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Vascular Graft Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Endovascular Stent Graft
14.2.2. Peripheral Vascular Graft
14.2.3. Hemodialysis Access Graft
14.2.4. Bypass Graft
14.2.5. Others
14.3. Market Value Forecast, by Source, 2017–2031
14.3.1. Synthetic
14.3.1.1. Polytetrafluethylene (PTFE)
14.3.1.2. Polyurethane (PU)
14.3.1.3. Dacron
14.3.1.4. Others
14.3.2. Biological
14.3.2.1. Bovine Vein
14.3.2.2. Saphenous Vein
14.3.2.3. Others
14.3.3. Biosynthetic
14.3.3.1. Ovine Collagen with Polyester
14.3.3.2. Others
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Coronary Artery Disease
14.4.2. Aneurysm
14.4.3. Vascular Occlusion
14.4.4. Renal Failure
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Cardiac Catheterization Laboratories
14.5.4. Specialty Clinics
14.5.5. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Source
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Vascular Graft Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2017–2031
15.2.1. Endovascular Stent Graft
15.2.2. Peripheral Vascular Graft
15.2.3. Hemodialysis Access Graft
15.2.4. Bypass Graft
15.2.5. Others
15.3. Market Value Forecast, by Source, 2017–2031
15.3.1. Synthetic
15.3.1.1. Polytetrafluethylene (PTFE)
15.3.1.2. Polyurethane (PU)
15.3.1.3. Dacron
15.3.1.4. Others
15.3.2. Biological
15.3.2.1. Bovine Vein
15.3.2.2. Saphenous Vein
15.3.2.3. Others
15.3.3. Biosynthetic
15.3.3.1. Ovine Collagen with Polyester
15.3.3.2. Others
15.4. Market Value Forecast, by Application, 2017–2031
15.4.1. Coronary Artery Disease
15.4.2. Aneurysm
15.4.3. Vascular Occlusion
15.4.4. Renal Failure
15.4.5. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Cardiac Catheterization Laboratories
15.5.4. Specialty Clinics
15.5.5. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product Type
15.7.2. By Source
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2020
16.3. Company Profiles
16.3.1. LaMaitre Vascular, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. B. Braun Melsungen AG
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. C. R. Bard, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. Cook Medical
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Medtronic plc
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. ArteGrafts, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Vascutek Ltd.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. Vascular Grafts Solution Ltd.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Heart Medical Europe BV
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. W. L. Gore & Associates, Inc.
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings